Anti-cancer activity of a new non-steroidal anti-angiogenic microtubule disruptor in breast cancer

被引：0
|
作者：
Stengel, Chloe
Newman, Simon
Foster, Paul
Leese, Mathew
Ferrandis, Eric
Regis-Lydi, Sandra
Potter, Barry
Reed, Michael
Purohit, Atul
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Univ Bath, Bath BA2 7AY, Avon, England
[3] Ipsen, Les Ulis, France
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2946
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities
    Prudent, Renaud
    Vassal-Stermann, Emilie
    Chi-Hung Nguyen
    Mollaret, Marjorie
    Viallet, Jean
    Desroches-Castan, Agnes
    Martinez, Anne
    Barette, Caroline
    Pillet, Catherine
    Valdameri, Glaucio
    Soleilhac, Emmanuelle
    Di Pietro, Attilio
    Feige, Jean-Jacques
    Billaud, Marc
    Florent, Jean-Claude
    Lafanechere, Laurence
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (03) : 673 - 685
  • [2] New thalidomide analogues; Anti-cancer, anti-angiogenic and immunostimulatory.
    Dalgleish, A
    Marriott, J
    Czajka, A
    Clarke, I
    Dredge, K
    Muller, G
    Stirling, D
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 : 25 - 25
  • [3] Perfluorinated ruthenium(II) complexes with improved anti-angiogenic or anti-cancer activity
    Nowak-Sliwinska, Patrycja
    Clavel, Catherine M.
    Paunescu, Emilia
    Griffioen, Arjan W.
    Dyson, Paul J.
    [J]. ANGIOGENESIS, 2014, 17 (03) : 768 - 768
  • [4] Anti-angiogenic treatment for breast cancer?
    van Netten, Johannes Pieter
    Cann, Stephen Hoption
    Thornton, Ian
    Finegan, Rory P.
    Maxwell, Chris
    [J]. CANCER TREATMENT REVIEWS, 2017, 55 : 230 - 230
  • [5] Anti-angiogenic therapy in breast cancer
    Rahman, MA
    Toi, M
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2003, 57 (10) : 463 - 470
  • [6] Non-steroidal anti-estrogens in the treatment of breast cancer
    Barker, Stewart
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (12) : 1085 - 1091
  • [7] Atiprimod is a novel anti-angiogenic and anti-cancer drug candidate.
    Shailubhai, K
    Dheer, SK
    Picker, D
    Kaur, G
    Sausville, E
    Jacob, GS
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6146S - 6146S
  • [8] CENTCHROMAN - A NON-STEROIDAL ANTI-CANCER AGENT FOR ADVANCED BREAST-CANCER - PHASE-II STUDY
    MISRA, NC
    NIGAM, PK
    GUPTA, R
    AGARWAL, AK
    KAMBOJ, VP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) : 781 - 783
  • [9] Anti-angiogenic strategies in breast cancer: An update
    Gropper A.B.
    Mayer E.L.
    [J]. Current Breast Cancer Reports, 2010, 2 (4) : 174 - 181
  • [10] Anti-Compression and Anti-Angiogenic Therapy for Breast Cancer
    Jiang, Amanda
    Mammoto, Tadanori
    Jiang, Elisabeth
    Ingber, Donald
    Mammoto, Akiko
    [J]. FASEB JOURNAL, 2015, 29
12345